Initial Laboratory and Imaging Tests for Chest Pain Evaluation
For patients presenting with chest pain, initial evaluation should include an ECG within 10 minutes of arrival, cardiac troponin measurement, and a chest radiograph to evaluate for cardiac, pulmonary, and other thoracic causes of symptoms. 1
Initial Assessment
History and Physical Examination
- A focused history should include pain characteristics (nature, onset, duration, location, radiation, precipitating/relieving factors) and associated symptoms to help identify potential cardiac causes 1
- Women require special attention as they may present with more accompanying symptoms (shortness of breath, fatigue) rather than classic chest pain 1
- In patients ≥75 years, ACS should be considered when accompanying symptoms like shortness of breath, syncope, acute delirium, or unexplained falls are present 1
- A focused cardiovascular examination should be performed to identify potential serious causes of chest pain and complications 1
Immediate Testing
Electrocardiogram (ECG)
- ECG should be performed within 10 minutes of arrival to evaluate for ST-segment elevation myocardial infarction (STEMI) 1
- Serial ECGs should be performed when clinical suspicion of ACS is high, symptoms persist, or clinical condition deteriorates 1
- Supplemental ECG leads V7-V9 are reasonable when posterior MI is suspected with intermediate-to-high clinical suspicion for ACS 1
Laboratory Tests
- Cardiac troponin should be measured as soon as possible after presentation in patients with suspected ACS 1
- For high-sensitivity troponin assays, recommended repeat measurement intervals are 1-3 hours after initial sample 1
- For conventional troponin assays, repeat measurements should be taken 3-6 hours after initial sample 1
- Additional laboratory tests should include hemoglobin (to detect anemia) and other markers of myocardial damage 1
Chest Radiography
- A chest radiograph is useful to evaluate for cardiac, pulmonary, and other thoracic causes of chest pain 1
- Chest X-ray can help identify conditions such as pneumonia, pneumothorax, pleural effusion, and intrathoracic tumors 1
Risk Stratification and Additional Testing
Risk Assessment
- Clinical decision pathways (CDPs) should categorize patients into low-, intermediate-, and high-risk strata to facilitate disposition and subsequent diagnostic evaluation 1
- Previous testing, when available, should be incorporated into clinical decision pathways 1
Additional Testing Based on Risk Level
- High-risk patients: Consider invasive coronary angiography 1
- Intermediate-risk patients: Consider anatomic or functional testing 1
- Low-risk patients: May defer testing or consider optional testing such as ECG or coronary artery calcium (CAC) scan 1
Special Considerations for Low-Risk Patients
- For patients with acute chest pain, normal ECG, and symptoms that began at least 3 hours before ED arrival, a single high-sensitivity troponin concentration below the limit of detection may reasonably exclude myocardial injury 1
- In patients with low suspicion for ACS, consider other diagnoses such as chest wall pain, costochondritis, gastroesophageal reflux disease, or anxiety 2
Pitfalls and Caveats
- Delayed transfer to the ED for troponin or other diagnostic testing should be avoided in patients initially evaluated in the office setting 1
- Normal ECG does not rule out ACS; careful history, clinical examination, and laboratory tests are still needed 1
- Chest pain characteristics alone are not powerful enough to rule out ACS without diagnostic testing 3
- The risk of discharging patients without correctly diagnosing ACS is significant without proper observation 1
By following this systematic approach to the evaluation of chest pain, clinicians can efficiently identify patients with life-threatening conditions while appropriately triaging those with less serious causes.